Literature DB >> 4186168

Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis.

N L Browse, J H Hall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4186168     DOI： 10.1016/s0140-6736(69)90429-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

1.  The effect of dextran on the lysability of ex vivo thrombi.

Authors:  M Aberg; S E Bergentz; U Hedner
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

2.  THE PATHOGENESIS OF PULMONARY ARTERIOSCLEROSIS: PROPHYLAXIS WITH DRUGS WHICH AFFECT PLATELET AGGREGATION.

Authors:  Michael Nihill
Journal:  Cardiovasc Dis       Date:  1974

3.  Prophylaxis of venous thromboembolism.

Authors:  V V Kakkar
Journal:  Proc R Soc Med       Date:  1975-04

4.  Prevention of postoperative deep venous thrombosis.

Authors: 
Journal:  Br Med J       Date:  1976-11-13

5.  Review of present status of prophylaxis of venous thromboembolism.

Authors:  V V Kakkar
Journal:  Proc R Soc Med       Date:  1974-08

Review 6.  Thromboembolism. Diagnosis and treatment.

Authors: 
Journal:  West J Med       Date:  1974-03

Review 7.  Local and systemic factors in the pathogenesis of thrombosis.

Authors:  D Deykin
Journal:  Calif Med       Date:  1970-03

8.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

9.  Prevention of postoperative deep venous thrombosis and pulmonary embolism.

Authors:  A E Carter; R Eban; R D Perrett
Journal:  Br Med J       Date:  1971-02-06

Review 10.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.